A study explores how AI and ML can improve early detection of neurological diseases, including Parkinson’s disease, ...

The open-label trial enrolled patients aged between two and 12 years who have a clinical diagnosis of Dravet syndrome.

A Yale researcher told Newsweek one newly identified Parkinson's target is already being tested in trials.

Researchers developed a low-cost sensor that detects dopamine in artificial tears, offering a potential non-invasive way to ...

(Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and ...

A study from the laboratory of Dr. Hugo J. Bellen, a distinguished service professor at Baylor College of Medicine and a principal investigator at the Jan and Dan Duncan Neurological Research ...

One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, according to a new systematic analysis by the American Academy of Neurology ...

IIT Madras researchers have achieved a milestone in neurological research by developing a 3D atlas of the human brainstem - ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the first participant has been dosed in the Phase 1-2 ASCEND study of ION337, an investigational RNA-targeted medicine for people living ...

The FDA determined the condition qualifies as a rare pediatric disease because it is a serious disorder that primarily affects patients from birth through age 18, Vanda said. The ...

Although sometimes portrayed in film and television as simply "falling asleep without warning," the reality of narcolepsy is ...

Canadian podcaster Dr. Jordan Peterson is broadcasting old lectures on Sundays while battling health issues. The 64-year-old author and provocateur announced on social media that he’ll ...